Word count (not including title, abstract, research in context, acknowledgment, references, tables, and figure legends): 5,077
RESEARCH IN CONTEXTEvidence before this study: Our PubMed search for articles matching the terms ("metagenomic" OR "cell-free DNA") and "infect*" in the title/abstract and using the "Human" species filter from inception to September 30, 2019 yielded 463 articles. Many proof-of-concept and validation studies illustrating how metagenomic sequencing can diagnose infections have been previously reviewed. Our search identified only nine studies which applied metagenomic shotgun sequencing to blood specimens, likely because there is a relatively low signal-to-noise ratio with this specimen type in this setting. In a study of 358 febrile sepsis patients, plasma cell-free DNA sequencing detected causative agents missed by standard-of-care testing in 15% of patients, but also detected bacterial organisms adjudicated as commensals in 10% of patients.Recently, a proof-of-concept study used machine learning to integrate metagenomic sequencing and transcriptional host response profiling to differentiate pathogens from commensal organisms in respiratory specimens, albeit with only a small derivation cohort to train host response signatures.Added value of this study: Our 200-patient study assessed the clinical utility of combining both metagenomic sequencing and a previously-defined host response assay to diagnose sepsis. We developed a rigorous chart review approach to measure whether our assays' results could change a physician's diagnostic decision-making, without having to commit the assays into patient care. Metagenomic sequencing revealed previously-undetected and clinically relevant organisms in 17 of 200 patients, and host response profiling led at least two of three physician chart reviewers to change SUMMARY Background: Current diagnostic techniques are inadequate for rapid microbial diagnosis and optimal management of patients with suspected sepsis. We assessed the impact of metagenomic sequencing and host response profiling individually and in combination on microbiological diagnosis in these patients.
Methods:In this cohort study of 200 consecutive patients with suspected sepsis we evaluated three molecular diagnostic methods with blood specimens: 1) direct bacterial DNA detection and characterization with metagenomic shotgun next generation sequencing and contaminant sequence removal using Bayesian inference; 2) direct viral DNA and RNA enrichment and detection with viral capture sequencing; and 3) transcript-based host response profiling with a previously-defined 18-gene qRT-PCR assay. We then evaluated changes in diagnostic decision-making among three expert physicians in a chart review by unblinding our three molecular test results in a staged fashion.Findings: Metagenomic shotgun sequencing confirmed positive blood culture results in 14 of 26 patients. In 17 of 200 patients, metagenomic sequencing and viral capture sequencing revealed organisms that were 1) not detected by conventional...